Table 1.
Demographic, clinical, and histopathological findings in 12 patients with HL diagnosed primarily in BM
| Patient | Sex | Age (years) | Risk factor | CD4 | HCV | LDH |
|---|---|---|---|---|---|---|
| #1 | M | 26 | IVDU | ND | Pos | ND |
| #2 | F | 29 | IVDU | ND | Pos | ND |
| #3 | M | 27 | IVDU | 195 | Pos | ND |
| #4 | M | 34 | IVDU | 17 | Pos | ND |
| #5 | M | 26 | IVDU | 39 | Pos | ND |
| #6 | M | 31 | IVDU | 123 | Pos | ND |
| #7 | M | 49 | UHSC | 52 | Neg | 600 |
| #8 | M | 40 | IVDU | 56 | Pos | 796 |
| #9 | M | 35 | UHSC | 104 | Neg | 318 |
| #10 | M | 41 | UHSC | 237 | ND | 390 |
| #11 | M | 51 | UHSC | 282 | Neg | 638 |
| #12 | M | 42 | IVDU | 198 | Pos | 360 |
M, male; F, female; HCV, hepatitis C virus; LDH, lactate dehydrogenase; IVDU, intravenous drug user; UHSC, unprotected heterosexual contact; Pos, positive; Neg, negative; ND, no data.